DiscoverInnovation and the Future of Pharmacovigilance
Innovation and the Future of Pharmacovigilance
Claim Ownership

Innovation and the Future of Pharmacovigilance

Author: Indy Ahluwalia

Subscribed: 2Played: 20
Share

Description

"Innovation and the Future of Pharmacovigilance" is a podcast series under our Truliant Talks platform. We dive into the fascinating world of drug safety, exploring ongoing challenges, cutting-edge technology, and future predictions in pharmacovigilance. 

Our expert guests provide a wealth of knowledge as they discuss topics from real-world data to post-marketing surveillance, ethical considerations, and beyond. This podcast is an invaluable resource for anyone interested in understanding how innovation is shaping the future of pharmacovigilance. Each episode promises insightful discussions, stimulating ideas, and the chance to keep abreast with the latest trends and issues in the field. 

Join us on this journey, deciphering the complex world of pharmacovigilance in an accessible and engaging manner.

17 Episodes
Reverse
Marie Pihl

Marie Pihl

2024-11-1850:08

Send us a textMarie Pihl’s journey from an assistant nurse with dreams of working in a children's hospital to becoming the Director of Operations, Technology, and Analytics in Global Patient Safety at AstraZeneca is nothing short of inspiring. Her story is one of perseverance, adaptability, and the power of commitment, as she balanced further education in molecular biology while raising three children. Marie's 21-year career at AstraZeneca, marked by pivotal experiences like training a vendor...
Thomas Kuckuk

Thomas Kuckuk

2024-11-0456:41

Send us a textWhat can we learn from a leader at the forefront of pharmacovigilance and risk management? Thomas Kuckuk, Head of System Operations Management at Novartis, offers an insightful journey through his career, weaving through medical informatics and into the heart of the pharmaceutical industry. This episode promises to illuminate the dynamics of safety technology and strategic program implementation, highlighting the critical differences between development and commercial settings t...
Sabura Matthews

Sabura Matthews

2024-10-2151:08

Send us a textSabura Matthews, a visionary in digital strategy for global patient safety, shares her transformative journey from the fast-paced world of trauma nursing to the strategic realm of pharmacovigilance. Her story begins amidst the chaotic energy of Philadelphia's trauma centers, where she honed her critical care skills. Facing professional challenges and yearning for growth, Sabura transitioned into clinical data management at SmithKline Beecham, where she discovered the powerful in...
Sibel Guerler

Sibel Guerler

2024-10-0755:29

Send us a textWhat do you get when you combine a background in neurobiology with a serendipitous introduction to pharmacovigilance? Join us as Sibel Guerler, Head of Strategy and Safety Evaluation at BMS, takes us on her remarkable journey, where life's unexpected turns have led to a fulfilling career in drug safety. Transitioning from managing databases and hard copies to embracing cutting-edge technologies, Sibel’s story is a testament to adaptability and the power of seizing opportunities....
Richard Wolf

Richard Wolf

2024-09-1643:56

Send us a textEver wondered how a liberal arts major, MBA holder, and former infantry officer navigates the complex world of pharmacovigilance? Our special guest, Richard Wolff, Vice President of Client Relations at RxLogix, shares his unique journey and insights. Richard's diverse background and rich experience at Johnson & Johnson tackling global adverse event reporting reveal the meticulous precision and regulatory understanding required in the field. Listen as Richard reflects on how ...
Nicole Baker

Nicole Baker

2024-04-0850:39

Send us a textEmbark on a captivating journey with Nicole Baker, the pioneering CEO of Biologit, as she shares her remarkable transition from academia to the forefront of pharmacovigilance on Truliant Talks. Nicole's narrative is not just about her personal evolution but also serves as an illuminating guide through the labyrinth of safety regulations and drug monitoring. Her candid conversation is a deep dive into the importance of patient safety, the impact of regulatory shifts, and the ever...
Bill Ringbloom

Bill Ringbloom

2024-03-2553:37

Send us a textEmbark on a transformational trek with Bill Ringbloom, AstraZeneca's Head of Global Patient Safety Technical Solutions as he shares his unconventional career trajectory from the financial chaos of 2008 to the cutting edge of pharmacovigilance. With a treasure trove of experience spanning IT, finance, and project management, Bill's insights shed light on the value of adaptable skill sets in the ever-evolving pharmaceutical domain. Tune in and uncover how the fusion of these diver...
Tom Nichols

Tom Nichols

2024-03-1149:22

Send us a textEmbark on an enlightening expedition, as we navigate the vital intricacies of pharmacovigilance and risk management alongside Tom Nichols, zoologist turned PV aficionado and Director of Drive Phase PV. Tom regales us with his unexpected but inspiring foray into the world of drug safety, stemming from a keen interest in epidemiology. His captivating tales underscore the importance of PV in delivering life-saving therapies to market, particularly through his work with Clozapine, a...
Colleen Walsh

Colleen Walsh

2024-02-2649:40

Send us a textDiscover the intricate world of pharmacovigilance as Colleen Walsh, the Vice President of Global Patient Safety Operations at Alnylam, unveils her personal journey through the ever-evolving landscape of patient safety. In this enthralling episode of Innovation and the Future of Pharmacovigilance, I sit down with Colleen to unravel the complexities she's encountered, from the pivotal Tysabri incident at BioGen to leading R&D compliance at Alexion. Her story is a testament to ...
Rishi Chopra

Rishi Chopra

2024-02-1247:28

Send us a textEmbark on an insightful exploration of pharmacovigilance with me, Indy Ahluwalia, as I sit down with industry trailblazer Rishi Chopra on Truliant Talks. Witness the fascinating narrative of Rishi's transition from biochemistry academia to becoming an instrumental figure in the pharmacovigilance space. His candid recount of the early days at Roche, where a nurturing community played a crucial role in his growth, sets the stage for a discussion full of personal anecdotes and pivo...
Michael Braun-Boghos

Michael Braun-Boghos

2024-01-2953:43

Send us a textEmbark on a journey through the dynamic world of pharmacovigilance with Michael Braun-Boghos, the seasoned Senior Director of Safety Strategy at Oracle. In our first episode of the season, Michael unpacks his three-decade odyssey from the analog days of adverse event forms to the digital frontier of pharmacovigilance. As we traverse his career landscape, the evolution from paper trails to strategic IT roles unfolds, highlighting pivotal shifts and the integrative prowess o...
Send us a textPrepare to have your perceptions of pharmacovigilance revolutionized as we're joined by the trailblazing co-founders of Truliant Consulting. We're peeling back the layers of AI's profound impact on the pharmaceutical industry, revealing how 2023's tech leaps are changing the game for drug safety. From the fascinating convergence of wearables and social media data to the necessity of keeping a laser focus on patient safety, this episode is a treasure trove of insights into the to...
Tony De Sousa

Tony De Sousa

2023-12-1151:25

Send us a textToday's conversation comes alive with Tony De Sousa, the Global Head of Countries and Regions at Novartis, leading the discourse on a fascinating journey through the world of pharmacovigilance. Tony's intriguing journey from nursing to becoming a significant player in one of the world's largest pharmaceutical companies is sure to captivate you. We delve deep into the evolution of PV, contemplating the influence of European regulations and the complexities of leading a global tea...
Catherine Kenny

Catherine Kenny

2023-11-2750:49

Send us a textEver wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it all. With years of experience spanning from a generics company to a director and head of Benefit Risk at Diamond Pharma Services, Catherine shares her invaluable insights into the intriguing world of PV.Does the prospect of smaller firms utilizing AI, in the face of budgetary an...
Sue Rees

Sue Rees

2023-11-1350:08

Send us a textImagine stepping into the world of pharmacovigilance with Sue Rees, founder of Sue Rees Consultancy, who has graced the industry for over three decades. As we stroll down memory lane, we relive Sue's fascinating progression from her rookie days at Smith, Kline & French's adverse events department to her critical QPPV roles across the continents. We unravel the compelling narrative of how Brexit prompted Sue's entrepreneurial journey and her contributions to the education sec...
Fraser McCullum

Fraser McCullum

2023-10-3050:321

Send us a textFeeling intimidated by the thought of AI transforming the world of pharmacovigilance? Join us as we sit down with Fraser McCullum, founder of Imagine Pharmacovigilance Limited, who has spent over 20 years navigating the dynamic landscape of this industry. From his time as a bench scientist to establishing his own company, Fraser offers an insightful perspective on case processing to signal detection, and the future of risk management in pharmacovigilance. Our conversation a...
Send us a textWelcome to Truliant Talks, your definitive source for the world of pharmacovigilance amd risk management.As we enter an era defined by innovation and technological advancement, Truliant Talks is proud to announce a new podcast series, 'Innovation and the Future of Pharmacovigilance'.This holistic series will tackle every perspective of pharmacovigilance - from the role of regulators, the importance of vendors, to embracing AI, data privacy, and much more.We'll feature leaders, i...